Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer. | NobleBlocks

Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer.

Public

Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer.

N

Shared by NobleBlocks on Oct 7, 2016 • 12:00 AM UTC

Authors:

G. Hortobagyi

,

S. Stemmer

,

H. Burris

Subject

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!

Publication Date: Oct 7, 2016 • 12:00 AM UTC

DOI:10.1056/NEJMOA1609709

No figures available

Scan for Errors

Scan for EDDII

Summarise

Generate Podcast